Codex DNA Demonstrates Momentum Toward Mission of Building World’s First Vaccine Printer and Global Vaccine Network
August 25, 2020 10:24 ET
|
Codex
San Diego, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, today announced critical advancements in its...
Codex DNA Launches New Automated Synthetic Biology Workstation for Commercial Use
August 18, 2020 09:15 ET
|
Codex
San Diego, Aug. 18, 2020 (GLOBE NEWSWIRE) -- The new BioXp™ 3250 system – a fully automated, benchtop platform for synthetic biology workflows – dramatically accelerates the development of critical...
Codex announces 8 new products to support the scientific community’s battle against COVID-19
April 09, 2020 09:08 ET
|
Codex
San Diego, April 09, 2020 (GLOBE NEWSWIRE) -- Codex DNA, Inc., creators of the world’s first fully automated system for high-throughput writing of DNA, the BioXp™ 3200 system, today announced a...
Conagen Receives a Strategic Investment from Sumitomo Chemical
March 31, 2020 15:51 ET
|
Conagen
Bedford, Mass., March 31, 2020 (GLOBE NEWSWIRE) -- Greater Boston-based biotech Conagen has received a strategic investment from Sumitomo Chemical, global chemical company in Japan. The investment...
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Highlight Camelina Platform for Producing PHB Biomaterials to Improve Water Quality at International Scientific Conference
October 04, 2019 08:30 ET
|
Yield10 Bioscience, Inc.
WOBURN, Mass., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company that uses its “Trait Factory” to develop high value seed traits for the...
Synthetic Biology Market To Reach USD 17.36 Billion By 2026 | Reports And Data
June 05, 2019 11:57 ET
|
Reports And Data
Increase in number of R&D investments in drug discovery, the improvement and reduced cost of DNA sequencing and synthesizing are the major factors influencing market growth. Market Size – USD...
Renaissance BioScience files PCT Patent Application for Yeast-based RNA Bioactive Molecule Production and Delivery Technology Platform
May 16, 2019 01:00 ET
|
Renaissance BioScience Corp.
VANCOUVER, British Columbia, May 16, 2019 (GLOBE NEWSWIRE) -- Renaissance BioScience Corp., a leading biological engineering company, is pleased to announce the filing on May 8, 2019 of a PCT patent...
Arzeda Leverages Scalable Synthetic Biology Resources to Drive Computational Protein Design Platform
October 02, 2018 08:00 ET
|
Arzeda
SEATTLE and SAN FRANCISCO, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, the Protein Design Company™, Twist Bioscience Corporation, TeselaGen Biotechnology Inc. and Labcyte Inc. have partnered to build...
Arzeda and BP Sign Collaborative Joint Development Agreement
October 02, 2018 08:00 ET
|
Arzeda
SEATTLE and HOUSTON, Oct. 02, 2018 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design Company™, and BP announced a collaboration to develop a process for producing a renewable chemical with broad...
Synthetic Biology Global Markets to Reach $13.9 Billion by 2022
July 11, 2018 08:00 ET
|
BCC Research
WELLESLEY, Mass, July 11, 2018 (GLOBE NEWSWIRE) -- Continuing advances in enabling technologies, such as DNA reading, writing, and editing, specialty media and bioinformatics, as well as a need for...